Blood samples from the patients, showed a higher concentration of testosterone than normal and a lower concentration of the female sex hormone oestrogen than normal. Both animal and human studies have shown that the brain is able to locally synthesize steroids de novo and is a target of steroid hormones. The role of 5α-DHT in women is not fully elucidated. If an individual is experiencing symptoms of bulimia, they need to contact a doctor or mental health professional. These findings are similar to what is observed across the menstrual cycle such that eating disorder symptoms increase when estradiol concentrations are low (i.e., postpartum) and decrease when estradiol concentrations are high (i.e., during pregnancy). It will be important for research to continue to build knowledge in this area before empirically supported hypotheses about the role of testosterone in eating disorder risk can be made. It has also been postulated that prenatal testosterone exposure plays an organizational role in eating disorder risk, such that it is protective against the development of an eating disorder. The majority of studies examining testosterone in eating disorders have only included acutely ill individuals. However, despite the significant positive association between binge-eating frequency and progesterone, a number of studies have indicated that progesterone does not have a direct effect on normal food intake, but it only increases food intake in the presence of estrogens by inhibiting the effects of estradiol. Notably, Edler et al. reported that estradiol and progesterone together accounted for 24% of the variance in binge eating in women with BN after controlling for negative affect . In summary, an increase in the attention paid to the role of reproductive hormones in eating disorder development in the past decade has important implications for the pathophysiology of eating disorders. Specifically, findings suggest that estradiol may play a role in the genetic vulnerability to eating disorder symptomatology. Thus, genetic factors specifically involved in the underlying regulation and functioning of the estrogen system, such as those involved in gene transcription and estrogen receptor signaling, may underlie the shared genetic risk observed between aspects of puberty and eating disorder symptoms. Similarly, studies have also addressed whether there are genetic associations between aspects of puberty and eating disorder symptoms. As posited above, women with eating disorders may have increased sensitivity to fluctuation, or change, in reproductive hormone concentrations. Most investigations of EDs among adolescent males has been conducted within a western cultural milieu, and overwhelmingly comprised of individuals who identify as white. Overall, in most cases, it seems that as male adolescents age, reported cognitive and behavioral ED symptoms seem to worsen, indicating that early intervention is of critical importance.18 Related to current issues with assessment among males is consideration of the age of ED onset among males, because research to date has been conflicting. However, there is no current diagnostic category that can accommodate inclusion of a muscularity-oriented body image as opposed to a thinness ideal. The removal of amenorrhea as a diagnostic criterion for AN within DSM-5 was an important step in improving accuracy in prevalence estimates among boys. Although there is increasing momentum within the field to focus specifically on the screening, assessment, and study of ED presentation among adolescent males, considerable efforts are required to attenuate to the knowledge base within the field, established for EDs among female peers. Moving both within and beyond a long history whereby men are consistently marginalized in screening, treatment, and research of EDs, there are several areas that receive the greatest impact from the traditionally held female-centric ED framework. Approximately 7–8 days before the preovulatory luteinizing hormone (LH) surge, the second half of the follicular phase begins, which is characterized by an increase in estradiol concentrations . The first day of menses is the beginning of the follicular phase, during the first half of which concentrations of estrogens and progesterone are stable and low . However, testosterone is secreted in women, primarily in the ovaries, with a small amount also secreted from the adrenal glands . Estrogens, progestogens and testosterone represent the classic reproductive hormones found in humans. There are probably many important, confounding, individual differences influencing sensitivity to reproductive hormone fluctuation. Exposure to this cultural thin ideal and the departure from it that typically happens during puberty (and other periods of reproductive axis change) may interact with an underlying genetic sensitivity to hormonal fluctuations. However, it appears that, at least for some individuals with BN, oral contraceptives and testosterone antagonists may be a beneficial adjunct to cognitive–behavioral therapy. The authors concluded that the administration of small, incremental doses of oral estradiol in girls 12–18 years of age with AN is effective in increasing spine and hip bone mass density . However, the impact of estradiol on additional AN symptomatology is not clear as this was not addressed in the report. However, physiological doses of estradiol show promising results for improving spine and hip bone mass density in girls with AN .
